Risedronate recalls

The FDA has published 3 recalls involving Risedronate since 2017. The latest was reported on 13 Apr 2022. Most were for potency & assay. Teva Pharmaceuticals U has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls3since 2017

Last 12 months0reported

Class I00% of total

Ongoing0latest 13 Apr 2022

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 0 0%Class III 3 100%

Why risedronate is recalled

Potency & Assay267%
Other Reasons133%

Companies

Teva Pharmaceuticals U267%
Macleods Pharma Usa133%

By year

2022133%
2017267%

All risedronate recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
13 Apr 2022Drug	CLASS III	Risedronate Sodium Tablets, USP, 5 mg recalled by Macleods Pharma UsaRisedronate Sodium	Macleods Pharma Usa	Other	Nationwide
15 Mar 2017Drug	CLASS III	Risedronate Sodium Delayed-release Tablets, 35 mg recalled	Teva Pharmaceuticals U	Potency & Assay	Nationwide
25 Jan 2017Drug	CLASS III	Risedronate Sodium Delayed-release Tablets, 35 mg recalled	Teva Pharmaceuticals U	Potency & Assay	Nationwide

Should you stop taking Risedronate?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.